Petros Pharmaceuticals, Inc. Quarterly Assets in USD from Q4 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Petros Pharmaceuticals, Inc. quarterly Assets history and growth rate from Q4 2020 to Q2 2024.
Petros Pharmaceuticals, Inc. Assets for the quarter ending June 30, 2024 was $25.2M, a 12.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$25.2M	-$3.56M	-12.4%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$30.3M	-$258K	-0.84%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$33.8M	+$1.37M	+4.24%	Dec 31, 2023	10-Q	2024-08-14
Q3 2023	$38.9M	+$1.22M	+3.23%	Sep 30, 2023	10-Q	2023-11-15
Q2 2023	$28.7M	-$22.3M	-43.7%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$30.6M	-$25.3M	-45.3%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$32.4M	-$35M	-51.9%	Dec 31, 2022	10-K	2024-04-01
Q3 2022	$37.7M	-$14.3M	-27.6%	Sep 30, 2022	10-Q/A	2022-11-15
Q2 2022	$51M	-$5.62M	-9.92%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$55.9M	-$10.3M	-15.6%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$67.4M	-$2.46M	-3.53%	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$52M			Sep 30, 2021	10-Q	2021-11-15
Q2 2021	$56.7M			Jun 30, 2021	10-Q	2021-08-16
Q1 2021	$66.2M			Mar 31, 2021	10-Q	2021-05-14
Q4 2020	$69.9M			Dec 31, 2020	10-K	2022-03-31

* An asterisk sign (*) next to the value indicates that the value is likely invalid.